Document is current

Article History

Received: 26 July 2021

Accepted: 12 November 2021

First Online: 4 December 2021

Declarations

:

: Not applicable.

: Not applicable.

: AG reports having received honoraria (Clovis, MSD, AstraZeneca, GSK, PharmaMar and Roche) and travel/accommodation/expenses (Merck Sharp & Dohme, PharmaMar, Roche, Eisai, Pfizer, Pierre-Fabre and Tesaro-A GSK Company) outside the submitted work. VM reports having received honoraria as speaker from Roche, Pfizer, Novartis, Lilly, Rovi and Bayer. JF has received consulting and advisory honoraria from Amgen, Ipsen, Eisai, Sirtex, Merck, Roche and Novartis; research funding from Merck; and travel and accommodation expenses from Amgen and Servier. AR reports having received honoraria and providing advisory/consultancy services (MSD, AstraZeneca, Roche, GSK, Clovis, PharmaMar, Lilly, Amgen), as well as having received research grant/funding to his institution (Eisai, PharmaMar, Roche), travel/accommodation/expenses (AstraZeneca, Tesaro: A GSK Company, PharmaMar, Roche), and participating in a speakers bureau (MSD, AstraZeneca, Roche, GSK, Clovis, PharmaMar) outside the submitted work. MM reports having received honoraria (MSD, AstraZeneca and GSK), research grant/funding to her institution (Eisai and PharmaMar), and travel/accommodation/expenses (AstraZeneca, GSK, PharmaMar, Roche and Pfizer) outside the submitted work. The remaining authors declare no conflicts of interest.